Posts by Stephanie Sivinski
The Federal Circuit’s decision in Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals, No. 2016-2707, addresses the complicated topic of patent eligibility in the pharmaceutical space. Much of …
is an Associate in the Intellectual Property Litigation Practice Groups in the Dallas office of Haynes and Boone, LLP. Her intellectual property and commercial litigation practice focuses on complex intellectual property and commercial disputes in the chemical and life sciences, including representation of generic pharmaceutical companies in Hatch-Waxman litigation. Her practice has also touched on topics as varied as thermodynamics, computer software, and semiconductor manufacturing.
For more information or to contact Stephanie, please visit her Firm Profile Page.